West Virginia Code of State Rules › Agency 24 - Osteopathic Medicine › Title 24 - LEGISLATIVE RULE WEST VIRGINIA BOARD OF OSTEOPATHIC MEDICINE › Series 24-01 - Licensing Procedures for Osteopathic Physicians › Section 24-1-3 - Definitions

Current through Register Vol. XLI, No. 28, July 12, 2024
3.1. Affiliate. --
				A member of a group of 2 or more fully accredited health care institutions
				legally united by an agreement of affiliation, conceived to enhance the
				potential of all participants in the provision of health care and medical
				education.
3.2. AOA. -- American
				Osteopathic Association
3.3.
				Approved program of post-graduate clinical training. -- A program of clinical
				training approved by, or subject to approval by, the American Osteopathic
				Association or approved by the Accreditation Council for Graduate Medical
				Education for the purposes of intern or resident training;
3.4. Board. -- The West Virginia Board of
				Osteopathic Medicine established in W. Va. Code §
									30-14-1
et
				seq
.
3.5. COMLEX-USA. --
				The Comprehensive Osteopathic Medical Licensing Examination of the United
				States.
3.6. Controlled substances.
				-- Drugs that are classified by federal or state law in Schedules I, II, III,
				IV, or V, as defined in W. Va. Code §§
									60A-2-204 through 212.
3.7. FCVS -- The Federation of State Medical
				Boards' Credentials Verification Service.
3.8. Immediate family -- A person within one
				degree of kinship of a physician or any relative living in the physician's
				household.
3.9. Opioid -- Natural
				and semi-synthetic derivatives of the opium poppy, as well as similar synthetic
				compounds that have analgesic or pain-relieving properties because of their
				effects in the central nervous system. These include, but are not limited to,
				codeine, morphine, hydromorphone, hydrocodone, oxycodone, methadone and
				fentanyl.
3.10. NBOME. -- The
				National Board of Osteopathic Medical Examiners.
3.11. Probation. -- Conditions and
				requirements imposed upon a licensee for a period of time that the board, in
				its discretion, determines to be justified under any provision of law. A
				licensee placed on probation may continue to practice subject to limitations
				imposed by the board, including the requirement that the licensee appear before
				the Board, or an officer or agent of the Board at such times and places as are
				designated by the Board. A licensee may be placed on probation without a
				previous or concurrent suspension or revocation of his or her
				license.
3.12. Risk Assessment and
				Responsible Prescribing of Controlled Substances -- Drug diversion training,
				best-practice prescribing of controlled substances training, and training on
				prescribing and administering an opioid antagonist which shall include all of
				the following components:
3.12.1. Risk
				Assessment and responding to drug diversion and drug seeking behavior,
				including:
3.12.1.a. Tools for conducting
				routine patient assessments for risk factors associated with drug diversion,
				misuse or abuse, and identification of substance use disorder treatment
				referral resources;
3.12.1.b. West
				Virginia specific statistics on prescription drug abuse and resulting
				deaths;
3.12.1.c. Identification of
				diversion and drug seeking tactics and behaviors;
3.12.1.d. Best practices for assessing,
				treating, and referring patients suspected of drug seeking behavior, diversion,
				or substance use disorder;
3.12.1.e. Introduction to Medication for
				Opioid Use Disorder (MOUD) and training on the effectiveness of MOUD treatment
				including the use of full opioid agonist, partial opioid agonist, and opioid
				antagonists; and
3.12.1.f. Training
				on the impacts of stigma on treatment effectiveness including the concept of
				addiction as a chronic disease.